Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Niagen Bioscience (NAGE) Times Interest Earned (2016 - 2022)

Historic Times Interest Earned for Niagen Bioscience (NAGE) over the last 14 years, with Q3 2022 value amounting to -$613.0.

  • Niagen Bioscience's Times Interest Earned fell 400.41% to -$613.0 in Q3 2022 from the same period last year, while for Jun 2023 it was -$1758.6, marking a year-over-year decrease of 16121.52%. This contributed to the annual value of -$492.24 for FY2021, which is 7602.89% down from last year.
  • Niagen Bioscience's Times Interest Earned amounted to -$613.0 in Q3 2022, which was down 400.41% from -$638.7 recorded in Q2 2022.
  • Niagen Bioscience's 5-year Times Interest Earned high stood at $1265.7 for Q4 2019, and its period low was -$966.5 during Q1 2022.
  • For the 5-year period, Niagen Bioscience's Times Interest Earned averaged around -$274.43, with its median value being -$380.06 (2020).
  • Over the last 5 years, Niagen Bioscience's Times Interest Earned had its largest YoY gain of 28774.67% in 2018, and its largest YoY loss of 125327.46% in 2018.
  • Quarter analysis of 5 years shows Niagen Bioscience's Times Interest Earned stood at $374.55 in 2018, then soared by 237.93% to $1265.7 in 2019, then tumbled by 130.03% to -$380.06 in 2020, then crashed by 55.41% to -$590.67 in 2021, then fell by 3.78% to -$613.0 in 2022.
  • Its Times Interest Earned stands at -$613.0 for Q3 2022, versus -$638.7 for Q2 2022 and -$966.5 for Q1 2022.